vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Lineage, Inc. (LINE). Click either name above to swap in a different company.
Lineage, Inc. is the larger business by last-quarter revenue ($1.4B vs $950.5M, roughly 1.4× Astrana Health, Inc.). Astrana Health, Inc. runs the higher net margin — 0.7% vs -7.3%, a 8.0% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 3.1%). Lineage, Inc. produced more free cash flow last quarter ($35.0M vs $-6.0M).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Norwegian Cruise Line Holdings (NCLH) is a holding company that is based in the United States and domiciled in Bermuda. It operates three cruise lines as wholly owned subsidiaries: Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. With its subsidiaries combined, it is the third-largest cruise operator in the world. It is a publicly traded company listed on the New York Stock Exchange.
ASTH vs LINE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.4B |
| Net Profit | $6.6M | $-100.0M |
| Gross Margin | — | 32.3% |
| Operating Margin | 1.9% | 2.5% |
| Net Margin | 0.7% | -7.3% |
| Revenue YoY | 42.9% | 3.1% |
| Net Profit YoY | 184.4% | 79.4% |
| EPS (diluted) | $0.12 | $-0.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | — | ||
| Q3 25 | $956.0M | $1.4B | ||
| Q2 25 | $654.8M | $1.4B | ||
| Q1 25 | $620.4M | $1.3B | ||
| Q4 24 | $665.2M | $1.3B | ||
| Q3 24 | $478.7M | $1.3B | ||
| Q2 24 | $486.3M | $1.3B | ||
| Q1 24 | $404.4M | $1.3B |
| Q4 25 | $6.6M | — | ||
| Q3 25 | $373.0K | $-100.0M | ||
| Q2 25 | $9.4M | $-6.0M | ||
| Q1 25 | $6.7M | $0 | ||
| Q4 24 | $-7.8M | $-71.0M | ||
| Q3 24 | $16.1M | $-485.0M | ||
| Q2 24 | $19.2M | $-68.0M | ||
| Q1 24 | $14.8M | $-40.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | 32.3% | ||
| Q2 25 | — | 31.9% | ||
| Q1 25 | — | 32.2% | ||
| Q4 24 | — | 32.3% | ||
| Q3 24 | — | 32.8% | ||
| Q2 24 | — | 33.4% | ||
| Q1 24 | — | 33.4% |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 2.0% | 2.5% | ||
| Q2 25 | 3.1% | 1.7% | ||
| Q1 25 | 3.3% | 4.3% | ||
| Q4 24 | 0.1% | -1.6% | ||
| Q3 24 | 5.9% | -38.6% | ||
| Q2 24 | 6.2% | 5.5% | ||
| Q1 24 | 7.5% | 7.6% |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.0% | -7.3% | ||
| Q2 25 | 1.4% | -0.4% | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | -1.2% | -5.3% | ||
| Q3 24 | 3.4% | -36.3% | ||
| Q2 24 | 3.9% | -5.1% | ||
| Q1 24 | 3.7% | -3.0% |
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.01 | $-0.44 | ||
| Q2 25 | $0.19 | $-0.03 | ||
| Q1 25 | $0.14 | $0.01 | ||
| Q4 24 | $-0.14 | $-0.52 | ||
| Q3 24 | $0.33 | $-2.44 | ||
| Q2 24 | $0.40 | $-0.46 | ||
| Q1 24 | $0.31 | $-0.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $8.4B |
| Total Assets | $2.2B | $19.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | — | ||
| Q2 25 | $342.1M | — | ||
| Q1 25 | $260.9M | — | ||
| Q4 24 | $290.8M | $173.0M | ||
| Q3 24 | $350.3M | $409.0M | ||
| Q2 24 | $327.7M | $73.0M | ||
| Q1 24 | $337.3M | — |
| Q4 25 | $779.3M | — | ||
| Q3 25 | $775.5M | $8.4B | ||
| Q2 25 | $765.5M | $8.6B | ||
| Q1 25 | $745.4M | $8.6B | ||
| Q4 24 | $712.7M | $8.6B | ||
| Q3 24 | $704.6M | $9.0B | ||
| Q2 24 | $678.9M | $4.9B | ||
| Q1 24 | $653.5M | $5.6B |
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $19.2B | ||
| Q2 25 | $1.4B | $19.4B | ||
| Q1 25 | $1.3B | $18.8B | ||
| Q4 24 | $1.4B | $18.7B | ||
| Q3 24 | $1.3B | $19.3B | ||
| Q2 24 | $1.3B | $18.8B | ||
| Q1 24 | $1.2B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $230.0M |
| Free Cash FlowOCF − Capex | $-6.0M | $35.0M |
| FCF MarginFCF / Revenue | -0.6% | 2.5% |
| Capex IntensityCapex / Revenue | 0.3% | 14.2% |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | — | ||
| Q3 25 | $10.0M | $230.0M | ||
| Q2 25 | $90.9M | $258.0M | ||
| Q1 25 | $16.6M | $139.0M | ||
| Q4 24 | $-10.9M | — | ||
| Q3 24 | $34.0M | $186.0M | ||
| Q2 24 | $23.2M | $155.0M | ||
| Q1 24 | $6.0M | $105.0M |
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | $35.0M | ||
| Q2 25 | $89.5M | $95.0M | ||
| Q1 25 | $13.6M | $-12.0M | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | $33.0M | ||
| Q2 24 | $20.4M | $-31.0M | ||
| Q1 24 | $5.6M | $-42.0M |
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | 2.5% | ||
| Q2 25 | 13.7% | 7.0% | ||
| Q1 25 | 2.2% | -0.9% | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | 2.5% | ||
| Q2 24 | 4.2% | -2.3% | ||
| Q1 24 | 1.4% | -3.2% |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | 14.2% | ||
| Q2 25 | 0.2% | 12.1% | ||
| Q1 25 | 0.5% | 11.7% | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | 11.5% | ||
| Q2 24 | 0.6% | 13.9% | ||
| Q1 24 | 0.1% | 11.1% |
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
LINE
| Warehousing Operations | $883.0M | 64% |
| Other | $308.0M | 22% |
| Warehouse Lease | $60.0M | 4% |
| Food Sales | $52.0M | 4% |
| E Commerce And Other | $46.0M | 3% |
| Railcar Lease | $23.0M | 2% |
| Service Other | $5.0M | 0% |
